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cyclic guanylic acid (the direct signaling 
molecule whose synthesis is increased on 
NO activation) nor the mRNA expression 
of endothelial NO synthases in skin biop-
sies was different. These studies show that 
the G894T polymorphism is a functional 
variant in humans and is worth studying in 
a large cohort. See page 327.
Infections following 
kidney transplantation
Improvements in kidney and patient sur-
vival following transplantation have been 
achieved in recent years. However, infec-
tions in these immune-compromised 
patients remain a significant complication. 
Snyder et al. reveal more about this prob-
lem by examining the incidence, trends, 
and clinical correlates of infections follow-
ing kidney transplantation in the United 
States Renal Data System during the years 
1995–2003 in 46,471 adults. Their findings 
show that infections with cytomegalovirus 
have declined while infections with hepa-
titis C have increased. The risk factors in 
Endothelial nitric 
oxide synthase gene 
polymorphisms and 
renal hemodynamics
Recent progress in the construction of the 
human HapMap, with its identification of 
a large number of single-nucleotide poly-
morphisms (SNPs), has provided new 
information on the association between a 
given SNP and disease incidence or out-
come. Commercial entities have been set 
up to perform these studies, which have not 
revealed the function of the gene of interest 
when a polymorphism is identified. Kidney 
International is now delighted to publish a 
paper by Cherney et al. that reveals a gene’s 
function. Nitric oxide (NO) is synthesized 
by a number of synthases, one of which is 
present in endothelial cells and contains sev-
eral polymorphisms. Since NO is generated 
by endothelial synthases from circulating 
l-arginine, the authors infused l-arginine 
in subjects who had one or another of the 
polymorphisms. They then measured the 
change in renal hemodynamics induced by 
the l-arginine infusion. The polymorphism 
of interest was at position 894, where a G 
could substitute for a T. Subjects with a GG 
genotype had lower blood pressure and sig-
nificant changes in effective renal plasma 
flow, glomerular filtration rate, filtration 
fraction, renal vascular resistance, and renal 
blood flow. On the other hand, subjects with 
a GT/TT genotype had a blunted response. 
However, neither the levels of circulating 
patients with infections include diabetes, 
cadaveric transplants, older age, and longer 
time on dialysis before transplantation. No 
improvements were found in the incidence 
of infections in the past decade. These find-
ings present an opportunity to combat 
post-transplant infections, since it appears 
that nephrologists have reached their limits 
using current therapies. See page 317.
Phosphate 
replacement in children 
on continuous renal 
replacement therapy
In a study presented in this issue, Santiago 
et al. found that the majority of infants and 
children undergoing continuous renal 
replacement therapy developed hypophos-
phatemia. As treatment progressed, almost 
two-thirds of the patients developed reduced 
serum phosphate concentrations. One-third 
of these patients required phosphate treat-
ments after the end of dialysis or hemofil-
tration. Adding phosphate to the dialysate 
solutions did not cause any instability of the 
mixtures or other complications. Needless 
to say, these children did not develop hypo-
phosphatemia or hyperphosphatemia after 
the end of dialysis. Given that hypophos-
phatemia can have serious consequences, 
especially for neuromuscular excitability, 
controlling the plasma phosphate levels in 
pediatric patients is an important objective. 
See page 312. 
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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